CovidV1, Istex, Corpus, bibRecord, 000738

VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS

Identifieur interne : 000738 ( Istex/Corpus ); précédent : 000737; suivant : 000739

VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS

Auteurs : D. A. S. Compston ; B. N. Vakarelis ; E. Paul ; W. I. Mcdonald ; J. R. Batchelor ; C. A. Mims

Source :

Brain [ 0006-8950 ] ; 1986.

RBID : ISTEX:48A89B6B4032DE997A251F270CA85B1BB81F5710

Abstract

Retrospective comparisons of the prevalence and age, where appropriate, of some childhood infectious illnesses and vaccinations, together with serological evidence for exposure to 16 viruses, many of which have previously been implicated in the aetiology of multiple sclerosis (MS) were made in 177 patients with acute optic neuritis, other recent isolated demyelinating episodes or established MS and 164 controls The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+), the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3-). Cases were compared with controls, collectively and in analyses restricted to each genetic group; these comparisons were repeated considering the three categories of patients with demyelination and two control populations separately All DR2+, DR3+ and DR2/3 individuals were compared in a single analysis to assess the effect of HLA type itself on the results Patients with demyelinating disease had rubella and measles at a later age and reported mumps infection more frequently than controls. Age of typhoid vaccination and duration of exposure to domestic dogs was higher in all cases than controls. Age of measles and mumps, but not rubella, was higher in DR2 + cases than controls, but differences were not observed in the other genetic groups Higher rubella antibody titres were present in all cases than controls and in analyses confined to DR2+ individuals in whom higher Epstein Barr virus antibody titres were also present Measles haemagglutination inhibition and parainfluenza I antibody titres were increased and influenza A antibodies detected less frequently in all patients with optic neuntis and those with DR2 compared with appropnate controls; influenza B antibody titres were lower in all DR2+ cases than controls. Higher adenovirus and varicella zoster antibody titres were present in DR2/3 patients with demyelination and other neurological diseases compared with normal controls. Overall, older age of infection and higher antibody titres were observed more often in patients with optic neuritis, in particular DR2 + cases, than other individuals with demyelination or controls. Our serological results are consistent with the presence of abnormal HLA mmunological reactivity in patients with MS but cannot be explained only by an effect of DR type itself; age at which susceptible individuals develop some common childhood infections may also influence the subsequent development of the disease.

Url:

https://api.istex.fr/ark:/67375/HXZ-55WJ0TLQ-V/fulltext.pdf

DOI: 10.1093/brain/109.2.325

Links to Exploration step

ISTEX:48A89B6B4032DE997A251F270CA85B1BB81F5710

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS</title>
<author><name sortKey="Compston, D A S" sort="Compston, D A S" uniqKey="Compston D" first="D. A. S." last="Compston">D. A. S. Compston</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Correspondence to. Dr D. A S Compston, Department of Neurology, University Hospital of Wales, Heath Park, CardiffCF4 4XW</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Vakarelis, B N" sort="Vakarelis, B N" uniqKey="Vakarelis B" first="B. N." last="Vakarelis">B. N. Vakarelis</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Paul, E" sort="Paul, E" uniqKey="Paul E" first="E." last="Paul">E. Paul</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mcdonald, W I" sort="Mcdonald, W I" uniqKey="Mcdonald W" first="W. I." last="Mcdonald">W. I. Mcdonald</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Batchelor, J R" sort="Batchelor, J R" uniqKey="Batchelor J" first="J. R." last="Batchelor">J. R. Batchelor</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mims, C A" sort="Mims, C A" uniqKey="Mims C" first="C. A." last="Mims">C. A. Mims</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:48A89B6B4032DE997A251F270CA85B1BB81F5710</idno>
<date when="1986" year="1986">1986</date>
<idno type="doi">10.1093/brain/109.2.325</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-55WJ0TLQ-V/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000738</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000738</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS</title>
<author><name sortKey="Compston, D A S" sort="Compston, D A S" uniqKey="Compston D" first="D. A. S." last="Compston">D. A. S. Compston</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Correspondence to. Dr D. A S Compston, Department of Neurology, University Hospital of Wales, Heath Park, CardiffCF4 4XW</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Vakarelis, B N" sort="Vakarelis, B N" uniqKey="Vakarelis B" first="B. N." last="Vakarelis">B. N. Vakarelis</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Paul, E" sort="Paul, E" uniqKey="Paul E" first="E." last="Paul">E. Paul</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mcdonald, W I" sort="Mcdonald, W I" uniqKey="Mcdonald W" first="W. I." last="Mcdonald">W. I. Mcdonald</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Batchelor, J R" sort="Batchelor, J R" uniqKey="Batchelor J" first="J. R." last="Batchelor">J. R. Batchelor</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mims, C A" sort="Mims, C A" uniqKey="Mims C" first="C. A." last="Mims">C. A. Mims</name>
<affiliation><mods:affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Brain</title>
<idno type="eISSN">1460-2156</idno>
<idno type="ISSN">0006-8950</idno>
<imprint><publisher>Oxford University Press</publisher>
<date when="1986-04">1986</date>
<biblScope unit="vol">109</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="325">325</biblScope>
<biblScope unit="page" to="344">344</biblScope>
</imprint>
<idno type="ISSN">0006-8950</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Retrospective comparisons of the prevalence and age, where appropriate, of some childhood infectious illnesses and vaccinations, together with serological evidence for exposure to 16 viruses, many of which have previously been implicated in the aetiology of multiple sclerosis (MS) were made in 177 patients with acute optic neuritis, other recent isolated demyelinating episodes or established MS and 164 controls The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+), the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3-). Cases were compared with controls, collectively and in analyses restricted to each genetic group; these comparisons were repeated considering the three categories of patients with demyelination and two control populations separately All DR2+, DR3+ and DR2/3 individuals were compared in a single analysis to assess the effect of HLA type itself on the results Patients with demyelinating disease had rubella and measles at a later age and reported mumps infection more frequently than controls. Age of typhoid vaccination and duration of exposure to domestic dogs was higher in all cases than controls. Age of measles and mumps, but not rubella, was higher in DR2 + cases than controls, but differences were not observed in the other genetic groups Higher rubella antibody titres were present in all cases than controls and in analyses confined to DR2+ individuals in whom higher Epstein Barr virus antibody titres were also present Measles haemagglutination inhibition and parainfluenza I antibody titres were increased and influenza A antibodies detected less frequently in all patients with optic neuntis and those with DR2 compared with appropnate controls; influenza B antibody titres were lower in all DR2+ cases than controls. Higher adenovirus and varicella zoster antibody titres were present in DR2/3 patients with demyelination and other neurological diseases compared with normal controls. Overall, older age of infection and higher antibody titres were observed more often in patients with optic neuritis, in particular DR2 + cases, than other individuals with demyelination or controls. Our serological results are consistent with the presence of abnormal HLA mmunological reactivity in patients with MS but cannot be explained only by an effect of DR type itself; age at which susceptible individuals develop some common childhood infections may also influence the subsequent development of the disease.</div>
</front>
</TEI>
<istex><corpusName>oup</corpusName>
<keywords><teeft><json:string>multiple sclerosis</json:string>
<json:string>demyelination</json:string>
<json:string>optic</json:string>
<json:string>rubella</json:string>
<json:string>sclerosis</json:string>
<json:string>optic neuritis</json:string>
<json:string>mumps</json:string>
<json:string>viral</json:string>
<json:string>neurology</json:string>
<json:string>demyelinating</json:string>
<json:string>relapse</json:string>
<json:string>relative risk</json:string>
<json:string>multiple comparison</json:string>
<json:string>demyelinating lesion</json:string>
<json:string>compston</json:string>
<json:string>neuritis</json:string>
<json:string>uncorrected</json:string>
<json:string>antibody titre</json:string>
<json:string>other neurological disease</json:string>
<json:string>parainfluenza</json:string>
<json:string>normal control</json:string>
<json:string>adenovirus</json:string>
<json:string>neurological</json:string>
<json:string>wallis</json:string>
<json:string>mumps infection</json:string>
<json:string>kruskal</json:string>
<json:string>zoster</json:string>
<json:string>measles</json:string>
<json:string>histocompatibility</json:string>
<json:string>varicella</json:string>
<json:string>significant difference</json:string>
<json:string>measles antibody</json:string>
<json:string>titre</json:string>
<json:string>viral infection</json:string>
<json:string>kruskal wallis analysis</json:string>
<json:string>aiidr3</json:string>
<json:string>idls</json:string>
<json:string>variance</json:string>
<json:string>control population</json:string>
<json:string>childhood infection</json:string>
<json:string>vaccination</json:string>
<json:string>varicella zoster</json:string>
<json:string>neurological science</json:string>
<json:string>higher antibody titre</json:string>
<json:string>genetic group</json:string>
<json:string>measles infection</json:string>
<json:string>lesion</json:string>
<json:string>influenza</json:string>
<json:string>infection</json:string>
<json:string>neurologica scandinavica</json:string>
<json:string>shetland island</json:string>
<json:string>typhoid vaccination</json:string>
<json:string>clinical infection</json:string>
<json:string>control group</json:string>
<json:string>rubella antibody</json:string>
<json:string>multiple sclerosis table</json:string>
<json:string>antibody</json:string>
<json:string>multiple sclerosis patient</json:string>
<json:string>epstein barr</json:string>
<json:string>queen square</json:string>
<json:string>tetanus toxoid vaccination</json:string>
<json:string>aiidr3 case</json:string>
<json:string>immune reactivity</json:string>
<json:string>clinical course</json:string>
<json:string>genetic susceptibility</json:string>
<json:string>others table</json:string>
<json:string>serological</json:string>
</teeft>
</keywords>
<author><json:item><name>D. A. S. COMPSTON</name>
<affiliations><json:string>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</json:string>
<json:string>Correspondence to. Dr D. A S Compston, Department of Neurology, University Hospital of Wales, Heath Park, CardiffCF4 4XW</json:string>
</affiliations>
</json:item>
<json:item><name>B. N. VAKARELIS</name>
<affiliations><json:string>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</json:string>
</affiliations>
</json:item>
<json:item><name>E. PAUL</name>
<affiliations><json:string>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</json:string>
</affiliations>
</json:item>
<json:item><name>W. I. McDONALD</name>
<affiliations><json:string>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</json:string>
</affiliations>
</json:item>
<json:item><name>J. R. BATCHELOR</name>
<affiliations><json:string>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</json:string>
</affiliations>
</json:item>
<json:item><name>C. A. MIMS</name>
<affiliations><json:string>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</json:string>
</affiliations>
</json:item>
</author>
<articleId><json:string>109.2.325</json:string>
</articleId>
<arkIstex>ark:/67375/HXZ-55WJ0TLQ-V</arkIstex>
<language><json:string>unknown</json:string>
</language>
<originalGenre><json:string>research-article</json:string>
</originalGenre>
<abstract>Retrospective comparisons of the prevalence and age, where appropriate, of some childhood infectious illnesses and vaccinations, together with serological evidence for exposure to 16 viruses, many of which have previously been implicated in the aetiology of multiple sclerosis (MS) were made in 177 patients with acute optic neuritis, other recent isolated demyelinating episodes or established MS and 164 controls The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+), the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3-). Cases were compared with controls, collectively and in analyses restricted to each genetic group; these comparisons were repeated considering the three categories of patients with demyelination and two control populations separately All DR2+, DR3+ and DR2/3 individuals were compared in a single analysis to assess the effect of HLA type itself on the results Patients with demyelinating disease had rubella and measles at a later age and reported mumps infection more frequently than controls. Age of typhoid vaccination and duration of exposure to domestic dogs was higher in all cases than controls. Age of measles and mumps, but not rubella, was higher in DR2 + cases than controls, but differences were not observed in the other genetic groups Higher rubella antibody titres were present in all cases than controls and in analyses confined to DR2+ individuals in whom higher Epstein Barr virus antibody titres were also present Measles haemagglutination inhibition and parainfluenza I antibody titres were increased and influenza A antibodies detected less frequently in all patients with optic neuntis and those with DR2 compared with appropnate controls; influenza B antibody titres were lower in all DR2+ cases than controls. Higher adenovirus and varicella zoster antibody titres were present in DR2/3 patients with demyelination and other neurological diseases compared with normal controls. Overall, older age of infection and higher antibody titres were observed more often in patients with optic neuritis, in particular DR2 + cases, than other individuals with demyelination or controls. Our serological results are consistent with the presence of abnormal HLA mmunological reactivity in patients with MS but cannot be explained only by an effect of DR type itself; age at which susceptible individuals develop some common childhood infections may also influence the subsequent development of the disease.</abstract>
<qualityIndicators><score>8</score>
<pdfWordCount>8034</pdfWordCount>
<pdfCharCount>51771</pdfCharCount>
<pdfVersion>1.2</pdfVersion>
<pdfPageCount>20</pdfPageCount>
<pdfPageSize>492 x 702 pts</pdfPageSize>
<pdfWordsPerPage>402</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>false</refBibsNative>
<abstractWordCount>387</abstractWordCount>
<abstractCharCount>2602</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS</title>
<pmid><json:string>3456817</json:string>
</pmid>
<genre><json:string>research-article</json:string>
</genre>
<host><title>Brain</title>
<language><json:string>unknown</json:string>
</language>
<issn><json:string>0006-8950</json:string>
</issn>
<eissn><json:string>1460-2156</json:string>
</eissn>
<publisherId><json:string>brainj</json:string>
</publisherId>
<volume>109</volume>
<issue>2</issue>
<pages><first>325</first>
<last>344</last>
</pages>
<genre><json:string>journal</json:string>
</genre>
<subject><json:item><value>Articles</value>
</json:item>
</subject>
</host>
<namedEntities><unitex><date><json:string>1986</json:string>
</date>
<geogName></geogName>
<orgName><json:string>Wellcome Laboratories</json:string>
<json:string>Mclndoe Memorial Research Unit, East Grinstead, and the Department of Tissue Immunology, Royal Postgraduate Medical School, Hammersmith Hospital</json:string>
<json:string>National Hospitals for Nervous Diseases, Queen Square</json:string>
<json:string>Northumbria Biologkals Ltd</json:string>
<json:string>Row Laboratories Ltd</json:string>
<json:string>National Hospitals for Nervous Diseases, Queen Square and Maida</json:string>
<json:string>Essex Ltd</json:string>
<json:string>Department of Microbiology, Guy</json:string>
<json:string>Department of Neurology, University Hospital of Wales, Heath Park, Cardiff CF</json:string>
<json:string>Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London W</json:string>
<json:string>Specific Specific Behnng Institute, West Germany</json:string>
<json:string>Oxford University</json:string>
<json:string>Guy's Hospital Medical School</json:string>
<json:string>USA Wellcome Laboratories</json:string>
<json:string>University of London</json:string>
<json:string>Medical Research Council</json:string>
</orgName>
<orgName_funder><json:string>Medical Research Council</json:string>
</orgName_funder>
<orgName_provider></orgName_provider>
<persName><json:string>Viral Serology</json:string>
<json:string>A. M. Halliday</json:string>
<json:string>A. Handley</json:string>
<json:string>Estimated</json:string>
<json:string>Gisela Enders</json:string>
<json:string>Andrew Jeavons</json:string>
<json:string>Maida Vale</json:string>
<json:string>Moira Weaver</json:string>
<json:string>Valerie McBroom</json:string>
<json:string>Groups</json:string>
<json:string>Jennifer Pearson</json:string>
<json:string>E. D. Acheson</json:string>
<json:string>D. McCance</json:string>
</persName>
<placeName><json:string>Specificity</json:string>
<json:string>London</json:string>
<json:string>United Kingdom</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl><json:string>Cook and Dowling, 1980</json:string>
<json:string>Poskanzer et al., 19806</json:string>
<json:string>Cohen et al., 1984</json:string>
<json:string>Compston, 1983</json:string>
<json:string>Jersild et al., 1973</json:string>
<json:string>Woyciechowska et al., 1982</json:string>
<json:string>Hauser et al., 1983</json:string>
<json:string>Salmi et al., 1982</json:string>
<json:string>Madden et al., 1981</json:string>
<json:string>Delasnerie-Laupretre et al., 1982</json:string>
<json:string>Dejaegher et al., 1983</json:string>
<json:string>Arnason et al., 1974</json:string>
<json:string>Johnson et al., 1980</json:string>
<json:string>Ho et al., 1982</json:string>
<json:string>Mertin et al., 1982</json:string>
<json:string>Bertrams et al., 1974</json:string>
<json:string>Jersild et al., 1973a</json:string>
<json:string>Currier et al. (1974)</json:string>
<json:string>Currier and Eldridge (1982)</json:string>
<json:string>Haile et al. (1982)</json:string>
<json:string>Engell et al., 1982</json:string>
<json:string>Link et al. (1973)</json:string>
<json:string>Tjernlund et al., 1984</json:string>
<json:string>Andersen et al., 1981</json:string>
<json:string>Sibley and Foley (1965)</json:string>
<json:string>Madigand et al., 1982</json:string>
<json:string>Sibley et al. (1985)</json:string>
<json:string>Paty et al., 1977</json:string>
<json:string>Poskanzer et al. (1980a)</json:string>
<json:string>Goust et al., 1982</json:string>
<json:string>Whitaker et al., 1976</json:string>
<json:string>Myers et al., 1976</json:string>
<json:string>Lamoureux et al., 1983</json:string>
<json:string>Sullivan et al. (1984)</json:string>
<json:string>Stendahl-Brodin et al., 1979</json:string>
<json:string>Fewster et al., 1977</json:string>
<json:string>Beebe et al., 1967</json:string>
<json:string>Ilonen et al., 1977</json:string>
<json:string>Antel et al., 1979</json:string>
<json:string>Visscher et al., 1981</json:string>
<json:string>Anderson et al. (1984)</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/HXZ-55WJ0TLQ-V</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - neurosciences</json:string>
<json:string>2 - clinical neurology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - neurology & neurosurgery</json:string>
</scienceMetrix>
<scopus><json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Clinical Neurology</json:string>
</scopus>
<inist><json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>1986</publicationDate>
<copyrightDate>1986</copyrightDate>
<doi><json:string>10.1093/brain/109.2.325</json:string>
</doi>
<id>48A89B6B4032DE997A251F270CA85B1BB81F5710</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-55WJ0TLQ-V/fulltext.pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-55WJ0TLQ-V/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/HXZ-55WJ0TLQ-V/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS</title>
<respStmt><resp>Références bibliographiques récupérées via GROBID</resp>
<name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name>
</respStmt>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Oxford University Press</publisher>
<availability><licence>© Oxford University Press</licence>
</availability>
<date type="Copyright" when="1986">1986</date>
<date when="1986-04">1986</date>
</publicationStmt>
<notesStmt><note type="content-type" source="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="publication-type" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="article"><analytic><title level="a" type="main" xml:lang="en">VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS</title>
<author xml:id="author-0000"><persName><surname>COMPSTON</surname>
<forename type="first">D. A. S.</forename>
</persName>
<affiliation><orgName type="institution">Institute of Neurology</orgName>
<orgName>Queen Square</orgName>
<orgName type="department">Department of Immunology</orgName>
<orgName type="department">Royal Postgraduate Medical School</orgName>
<orgName type="institution">Hammersmith Hospital</orgName>
<orgName type="department">Department of Microbiology</orgName>
<orgName type="institution">Guy's Hospital Medical School</orgName>
<address><addrLine>London WCIN 3BG</addrLine>
<addrLine>London W12 0HS</addrLine>
<addrLine>London Bridge SE1 9RT</addrLine>
</address>
</affiliation>
<affiliation role="corresp">Correspondence to. Dr D. A S Compston, Department of Neurology, University Hospital of Wales, Heath Park, CardiffCF4 4XW</affiliation>
</author>
<author xml:id="author-0001"><persName><surname>VAKARELIS</surname>
<forename type="first">B. N.</forename>
</persName>
<affiliation><orgName type="institution">Institute of Neurology</orgName>
<orgName>Queen Square</orgName>
<orgName type="department">Department of Immunology</orgName>
<orgName type="department">Royal Postgraduate Medical School</orgName>
<orgName type="institution">Hammersmith Hospital</orgName>
<orgName type="department">Department of Microbiology</orgName>
<orgName type="institution">Guy's Hospital Medical School</orgName>
<address><addrLine>London WCIN 3BG</addrLine>
<addrLine>London W12 0HS</addrLine>
<addrLine>London Bridge SE1 9RT</addrLine>
</address>
</affiliation>
</author>
<author xml:id="author-0002"><persName><surname>PAUL</surname>
<forename type="first">E.</forename>
</persName>
<affiliation><orgName type="institution">Institute of Neurology</orgName>
<orgName>Queen Square</orgName>
<orgName type="department">Department of Immunology</orgName>
<orgName type="department">Royal Postgraduate Medical School</orgName>
<orgName type="institution">Hammersmith Hospital</orgName>
<orgName type="department">Department of Microbiology</orgName>
<orgName type="institution">Guy's Hospital Medical School</orgName>
<address><addrLine>London WCIN 3BG</addrLine>
<addrLine>London W12 0HS</addrLine>
<addrLine>London Bridge SE1 9RT</addrLine>
</address>
</affiliation>
</author>
<author xml:id="author-0003"><persName><surname>McDONALD</surname>
<forename type="first">W. I.</forename>
</persName>
<affiliation><orgName type="institution">Institute of Neurology</orgName>
<orgName>Queen Square</orgName>
<orgName type="department">Department of Immunology</orgName>
<orgName type="department">Royal Postgraduate Medical School</orgName>
<orgName type="institution">Hammersmith Hospital</orgName>
<orgName type="department">Department of Microbiology</orgName>
<orgName type="institution">Guy's Hospital Medical School</orgName>
<address><addrLine>London WCIN 3BG</addrLine>
<addrLine>London W12 0HS</addrLine>
<addrLine>London Bridge SE1 9RT</addrLine>
</address>
</affiliation>
</author>
<author xml:id="author-0004"><persName><surname>BATCHELOR</surname>
<forename type="first">J. R.</forename>
</persName>
<affiliation><orgName type="institution">Institute of Neurology</orgName>
<orgName>Queen Square</orgName>
<orgName type="department">Department of Immunology</orgName>
<orgName type="department">Royal Postgraduate Medical School</orgName>
<orgName type="institution">Hammersmith Hospital</orgName>
<orgName type="department">Department of Microbiology</orgName>
<orgName type="institution">Guy's Hospital Medical School</orgName>
<address><addrLine>London WCIN 3BG</addrLine>
<addrLine>London W12 0HS</addrLine>
<addrLine>London Bridge SE1 9RT</addrLine>
</address>
</affiliation>
</author>
<author xml:id="author-0005"><persName><surname>MIMS</surname>
<forename type="first">C. A.</forename>
</persName>
<affiliation><orgName type="institution">Institute of Neurology</orgName>
<orgName>Queen Square</orgName>
<orgName type="department">Department of Immunology</orgName>
<orgName type="department">Royal Postgraduate Medical School</orgName>
<orgName type="institution">Hammersmith Hospital</orgName>
<orgName type="department">Department of Microbiology</orgName>
<orgName type="institution">Guy's Hospital Medical School</orgName>
<address><addrLine>London WCIN 3BG</addrLine>
<addrLine>London W12 0HS</addrLine>
<addrLine>London Bridge SE1 9RT</addrLine>
</address>
</affiliation>
</author>
<idno type="istex">48A89B6B4032DE997A251F270CA85B1BB81F5710</idno>
<idno type="ark">ark:/67375/HXZ-55WJ0TLQ-V</idno>
<idno type="publisher-id">109.2.325</idno>
<idno type="DOI">10.1093/brain/109.2.325</idno>
</analytic>
<monogr><title level="j" type="main">Brain</title>
<idno type="hwp">brain</idno>
<idno type="publisher-id">brainj</idno>
<idno type="pmc">brain</idno>
<idno type="eISSN">1460-2156</idno>
<idno type="pISSN">0006-8950</idno>
<imprint><publisher>Oxford University Press</publisher>
<date when="1986-04">1986</date>
<biblScope unit="vol">109</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="325">325</biblScope>
<biblScope unit="page" to="344">344</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-09"><label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
                        <ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc><abstract><p>Retrospective comparisons of the prevalence and age, where appropriate, of some childhood infectious illnesses and vaccinations, together with serological evidence for exposure to 16 viruses, many of which have previously been implicated in the aetiology of multiple sclerosis (MS) were made in 177 patients with acute optic neuritis, other recent isolated demyelinating episodes or established MS and 164 controls The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+), the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3-). Cases were compared with controls, collectively and in analyses restricted to each genetic group; these comparisons were repeated considering the three categories of patients with demyelination and two control populations separately All DR2+, DR3+ and DR2/3 individuals were compared in a single analysis to assess the effect of HLA type itself on the results</p>
<p>Patients with demyelinating disease had rubella and measles at a later age and reported mumps infection more frequently than controls. Age of typhoid vaccination and duration of exposure to domestic dogs was higher in all cases than controls. Age of measles and mumps, but not rubella, was higher in DR2 + cases than controls, but differences were not observed in the other genetic groups Higher rubella antibody titres were present in all cases than controls and in analyses confined to DR2+ individuals in whom higher Epstein Barr virus antibody titres were also present Measles haemagglutination inhibition and parainfluenza I antibody titres were increased and influenza A antibodies detected less frequently in all patients with optic neuntis and those with DR2 compared with appropnate controls; influenza B antibody titres were lower in all DR2+ cases than controls. Higher adenovirus and varicella zoster antibody titres were present in DR2/3 patients with demyelination and other neurological diseases compared with normal controls. Overall, older age of infection and higher antibody titres were observed more often in patients with optic neuritis, in particular DR2 + cases, than other individuals with demyelination or controls.</p>
<p>Our serological results are consistent with the presence of abnormal HLA mmunological reactivity in patients with MS but cannot be explained only by an effect of DR type itself; age at which susceptible individuals develop some common childhood infections may also influence the subsequent development of the disease.</p>
</abstract>
<textClass ana="subject"><keywords scheme="subject"><term>Articles</term>
</keywords>
</textClass>
<langUsage><language ident="EN"></language>
</langUsage>
</profileDesc>
<revisionDesc><change when="2019-12-09" who="#istex" xml:id="pub2tei">formatting</change>
<change xml:id="refBibs-istex" who="#ISTEX-API" when="2019-12-11">References added</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-55WJ0TLQ-V/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="corpus oup, element #text not found" wicri:toSee="no header"><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType>
<istex:document><article article-type="research-article">

<front>

<journal-meta>

<journal-id journal-id-type="hwp">brain</journal-id>

<journal-id journal-id-type="publisher-id">brainj</journal-id>

<journal-id journal-id-type="pmc">brain</journal-id>

<journal-title>Brain</journal-title>

<issn pub-type="epub">1460-2156</issn>

<issn pub-type="ppub">0006-8950</issn>

<publisher>

<publisher-name>Oxford University Press</publisher-name>

</publisher>

</journal-meta>

<article-meta>

<article-id pub-id-type="publisher-id">109.2.325</article-id>

<article-id pub-id-type="doi">10.1093/brain/109.2.325</article-id>

<article-categories>

<subj-group>

<subject>Articles</subject>

</subj-group>

</article-categories>

<title-group>

<article-title>VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS</article-title>

</title-group>

<contrib-group>

<contrib contrib-type="author">

<name><surname>COMPSTON</surname>
<given-names>D. A. S.</given-names>
</name>
<xref ref-type="corresp" rid="cor1"></xref>

</contrib>

<contrib contrib-type="author">

<name><surname>VAKARELIS</surname>
<given-names>B. N.</given-names>
</name>

</contrib>

<contrib contrib-type="author">

<name><surname>PAUL</surname>
<given-names>E.</given-names>
</name>

</contrib>

<contrib contrib-type="author">

<name><surname>McDONALD</surname>
<given-names>W. I.</given-names>
</name>

</contrib>

<contrib contrib-type="author">

<name><surname>BATCHELOR</surname>
<given-names>J. R.</given-names>
</name>

</contrib>

<contrib contrib-type="author">

<name><surname>MIMS</surname>
<given-names>C. A.</given-names>
</name>

</contrib>

<aff><institution>Institute of Neurology, Queen Square</institution>
 <addr-line>London WCIN 3BG</addr-line>
 <institution>Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital</institution>
 <addr-line>London W12 0HS</addr-line>
 <institution>Department of Microbiology, Guy's Hospital Medical School</institution>
 <addr-line>London Bridge SE1 9RT</addr-line>
</aff>

</contrib-group>

<author-notes>

<corresp id="cor1">Correspondence to. Dr D. A S Compston, Department of Neurology, University Hospital of Wales, Heath Park, CardiffCF4 4XW</corresp>

</author-notes>

<pub-date pub-type="ppub">

<month>4</month>

<year>1986</year>

</pub-date>

<volume>109</volume>

<issue>2</issue>

<fpage>325</fpage>

<lpage>344</lpage>

<history>

<date date-type="received">

<day>02</day>

<month>1</month>

<year>1985</year>

</date>

<date date-type="rev-recd">

<day>23</day>

<month>7</month>

<year>1985</year>

</date>

<date date-type="accepted">

<day>09</day>

<month>8</month>

<year>1985</year>

</date>

</history>

<copyright-statement>© Oxford University Press</copyright-statement>

<copyright-year>1986</copyright-year>

<abstract>

<p>Retrospective comparisons of the prevalence and age, where appropriate, of some childhood infectious illnesses and vaccinations, together with serological evidence for exposure to 16 viruses, many of which have previously been implicated in the aetiology of multiple sclerosis (MS) were made in 177 patients with acute optic neuritis, other recent isolated demyelinating episodes or established MS and 164 controls The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+), the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3-). Cases were compared with controls, collectively and in analyses restricted to each genetic group; these comparisons were repeated considering the three categories of patients with demyelination and two control populations separately All DR2+, DR3+ and DR2/3 individuals were compared in a single analysis to assess the effect of HLA type itself on the results</p>

<p>Patients with demyelinating disease had rubella and measles at a later age and reported mumps infection more frequently than controls. Age of typhoid vaccination and duration of exposure to domestic dogs was higher in all cases than controls. Age of measles and mumps, but not rubella, was higher in DR2 + cases than controls, but differences were not observed in the other genetic groups Higher rubella antibody titres were present in all cases than controls and in analyses confined to DR2+ individuals in whom higher Epstein Barr virus antibody titres were also present Measles haemagglutination inhibition and parainfluenza I antibody titres were increased and influenza A antibodies detected less frequently in all patients with optic neuntis and those with DR2 compared with appropnate controls; influenza B antibody titres were lower in all DR2+ cases than controls. Higher adenovirus and varicella zoster antibody titres were present in DR2/3 patients with demyelination and other neurological diseases compared with normal controls. Overall, older age of infection and higher antibody titres were observed more often in patients with optic neuritis, in particular DR2 + cases, than other individuals with demyelination or controls.</p>

<p>Our serological results are consistent with the presence of abnormal HLA mmunological reactivity in patients with MS but cannot be explained only by an effect of DR type itself; age at which susceptible individuals develop some common childhood infections may also influence the subsequent development of the disease.</p>

</abstract>

</article-meta>

</front>

</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo><title>VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA"><title>VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS</title>
</titleInfo>
<name type="personal"><namePart type="given">D. A. S.</namePart>
<namePart type="family">COMPSTON</namePart>
<affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</affiliation>
<affiliation>Correspondence to. Dr D. A S Compston, Department of Neurology, University Hospital of Wales, Heath Park, CardiffCF4 4XW</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">B. N.</namePart>
<namePart type="family">VAKARELIS</namePart>
<affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">E.</namePart>
<namePart type="family">PAUL</namePart>
<affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">W. I.</namePart>
<namePart type="family">McDONALD</namePart>
<affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">J. R.</namePart>
<namePart type="family">BATCHELOR</namePart>
<affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C. A.</namePart>
<namePart type="family">MIMS</namePart>
<affiliation>Institute of Neurology, Queen Square, London WCIN 3BG, London W12 0HS, London Bridge SE1 9RT</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo><publisher>Oxford University Press</publisher>
<dateIssued encoding="w3cdtf">1986-04</dateIssued>
<dateCreated encoding="w3cdtf">1985-08-09</dateCreated>
<copyrightDate encoding="w3cdtf">1986</copyrightDate>
</originInfo>
<abstract>Retrospective comparisons of the prevalence and age, where appropriate, of some childhood infectious illnesses and vaccinations, together with serological evidence for exposure to 16 viruses, many of which have previously been implicated in the aetiology of multiple sclerosis (MS) were made in 177 patients with acute optic neuritis, other recent isolated demyelinating episodes or established MS and 164 controls The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+), the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3-). Cases were compared with controls, collectively and in analyses restricted to each genetic group; these comparisons were repeated considering the three categories of patients with demyelination and two control populations separately All DR2+, DR3+ and DR2/3 individuals were compared in a single analysis to assess the effect of HLA type itself on the results Patients with demyelinating disease had rubella and measles at a later age and reported mumps infection more frequently than controls. Age of typhoid vaccination and duration of exposure to domestic dogs was higher in all cases than controls. Age of measles and mumps, but not rubella, was higher in DR2 + cases than controls, but differences were not observed in the other genetic groups Higher rubella antibody titres were present in all cases than controls and in analyses confined to DR2+ individuals in whom higher Epstein Barr virus antibody titres were also present Measles haemagglutination inhibition and parainfluenza I antibody titres were increased and influenza A antibodies detected less frequently in all patients with optic neuntis and those with DR2 compared with appropnate controls; influenza B antibody titres were lower in all DR2+ cases than controls. Higher adenovirus and varicella zoster antibody titres were present in DR2/3 patients with demyelination and other neurological diseases compared with normal controls. Overall, older age of infection and higher antibody titres were observed more often in patients with optic neuritis, in particular DR2 + cases, than other individuals with demyelination or controls. Our serological results are consistent with the presence of abnormal HLA mmunological reactivity in patients with MS but cannot be explained only by an effect of DR type itself; age at which susceptible individuals develop some common childhood infections may also influence the subsequent development of the disease.</abstract>
<note type="author-notes">Correspondence to. Dr D. A S Compston, Department of Neurology, University Hospital of Wales, Heath Park, CardiffCF4 4XW</note>
<relatedItem type="host"><titleInfo><title>Brain</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<subject><topic>Articles</topic>
</subject>
<identifier type="ISSN">0006-8950</identifier>
<identifier type="eISSN">1460-2156</identifier>
<identifier type="PublisherID">brainj</identifier>
<identifier type="PublisherID-hwp">brain</identifier>
<part><date>1986</date>
<detail type="volume"><caption>vol.</caption>
<number>109</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>325</start>
<end>344</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">48A89B6B4032DE997A251F270CA85B1BB81F5710</identifier>
<identifier type="ark">ark:/67375/HXZ-55WJ0TLQ-V</identifier>
<identifier type="DOI">10.1093/brain/109.2.325</identifier>
<identifier type="ArticleID">109.2.325</identifier>
<accessCondition type="use and reproduction" contentType="copyright">© Oxford University Press</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-GTWS0RDP-M">oup</recordContentSource>
<recordOrigin>Converted from  (version 1.2.0) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2019-12-09</recordCreationDate>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-55WJ0TLQ-V/record.json</uri>
</json:item>
</metadata>
<annexes><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/HXZ-55WJ0TLQ-V/annexes.pdf</uri>
</json:item>
</annexes>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000738 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000738 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:48A89B6B4032DE997A251F270CA85B1BB81F5710
   |texte=   VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS
}}

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021

	Serveur d'exploration Covid
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Covid

VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS

VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri